Kristof Van Emelen, a chemist and biotech executive, has joined Scenic Biotech BV of the Netherlands to lead drug discovery. In his new role, he will help develop genetic modifier-based small molecule drug candidates to treat severe diseases. Dr Van Emelen was previously head of medicinal chemistry at Ermium Therapeutics in France. He has also held management positions at ProDigest BV, a contract research organisation, and at Janssen Pharmaceutical Companies. Dr Van Emelen holds a PhD in organic chemistry and a Master of Science degree from KU Leuven in Belgium.
Scenic Biotech announced the appointment on 19 January 2023.
Copyright 2023 Evernow Publishing Ltd